Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection

205.479.01017 Boehringer Ingelheim Investigational Site, Tucson

205.479.01036 Boehringer Ingelheim Investigational Site, Riverside

205.479.01024 Boehringer Ingelheim Investigational Site, San Diego

205.479.01043 Boehringer Ingelheim Investigational Site, DeLand

205.479.01040 Boehringer Ingelheim Investigational Site, St. Petersburg

205.479.01022 Boehringer Ingelheim Investigational Site, Chelsea

205.479.01041 Boehringer Ingelheim Investigational Site, Picayune

205.479.01037 Boehringer Ingelheim Investigational Site, St Louis

205.479.01005 Boehringer Ingelheim Investigational Site, Tabor City

205.479.01008 Boehringer Ingelheim Investigational Site, Wilmington

205.479.01003 Boehringer Ingelheim Investigational Site, Cincinnati

205.479.01002 Boehringer Ingelheim Investigational Site, Pittsburgh

205.479.01044 Boehringer Ingelheim Investigational Site, Tipton

205.479.01006 Boehringer Ingelheim Investigational Site, Charleston

205.479.01001 Boehringer Ingelheim Investigational Site, Columbia

205.479.01007 Boehringer Ingelheim Investigational Site, Easley

205.479.01026 Boehringer Ingelheim Investigational Site, Fort Mill

205.479.01031 Boehringer Ingelheim Investigational Site, Gaffney

205.479.01012 Boehringer Ingelheim Investigational Site, Greenville

205.479.01048 Boehringer Ingelheim Investigational Site, Hodges

205.479.01004 Boehringer Ingelheim Investigational Site, Spartanburg

205.479.01019 Boehringer Ingelheim Investigational Site, Union

205.479.01039 Boehringer Ingelheim Investigational Site, Rapid City

205.479.01033 Boehringer Ingelheim Investigational Site, Chattanooga

205.479.01028 Boehringer Ingelheim Investigational Site, Killeen

205.479.01038 Boehringer Ingelheim Investigational Site, Ettrick

205.479.01047 Boehringer Ingelheim Investigational Site, Norfolk